Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease

Carlos Collet, Yoshinobu Onuma, Daniele Andreini, Jeroen Sonck, Giulio Pompilio, Saima Mushtaq, Mark La Meir, Yosuke Miyazaki, Johan de Mey, Oliver Gaemperli, Ahmed Ouda, Juan Pablo Maureira, Damien Mandry, Edoardo Camenzind, Laurent Macron, Torsten Doenst, Ulf Teichgräber, Holger Sigusch, Taku Asano, Yuki Katagiri, Marie-Angele Morel, Wietze Lindeboom, Gianluca Pontone, Thomas F Lüscher, Antonio L Bartorelli, Patrick W Serruys, Carlos Collet, Yoshinobu Onuma, Daniele Andreini, Jeroen Sonck, Giulio Pompilio, Saima Mushtaq, Mark La Meir, Yosuke Miyazaki, Johan de Mey, Oliver Gaemperli, Ahmed Ouda, Juan Pablo Maureira, Damien Mandry, Edoardo Camenzind, Laurent Macron, Torsten Doenst, Ulf Teichgräber, Holger Sigusch, Taku Asano, Yuki Katagiri, Marie-Angele Morel, Wietze Lindeboom, Gianluca Pontone, Thomas F Lüscher, Antonio L Bartorelli, Patrick W Serruys

Abstract

Aims: Coronary computed tomography angiography (CTA) has emerged as a non-invasive diagnostic method for patients with suspected coronary artery disease, but its usefulness in patients with complex coronary artery disease remains to be investigated. The present study sought to determine the agreement between separate heart teams on treatment decision-making based on either coronary CTA or conventional angiography.

Methods and results: Separate heart teams composed of an interventional cardiologist, a cardiac surgeon, and a radiologist were randomized to assess the coronary artery disease with either coronary CTA or conventional angiography in patients with de novo left main or three-vessel coronary artery disease. Each heart team, blinded for the other imaging modality, quantified the anatomical complexity using the SYNTAX score and integrated clinical information using the SYNTAX Score II to provide a treatment recommendations based on mortality prediction at 4 years: coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or equipoise between CABG and PCI. The primary endpoint was the agreement between heart teams on the revascularization strategy. The secondary endpoint was the impact of fractional flow reserve derived from coronary CTA (FFRCT) on treatment decision and procedural planning. Overall, 223 patients were included. A treatment recommendation of CABG was made in 28% of the cases with coronary CTA and in 26% with conventional angiography. The agreement concerning treatment decision between coronary CTA and conventional angiography was high (Cohen's kappa 0.82, 95% confidence interval 0.74-0.91). The heart teams agreed on the coronary segments to be revascularized in 80% of the cases. FFRCT was available for 869/1108 lesions (196/223 patients). Fractional flow reserve derived from coronary CTA changed the treatment decision in 7% of the patients.

Conclusion: In patients with left main or three-vessel coronary artery disease, a heart team treatment decision-making based on coronary CTA showed high agreement with the decision derived from conventional coronary angiography suggesting the potential feasibility of a treatment decision-making and planning based solely on this non-invasive imaging modality and clinical information.

Trial registration number: NCT02813473.

Figures

Figure 1
Figure 1
A flow chart of the study. FFRCT, fractional flow reserve derived from coronary computed tomography angiography.
Take home figure
Take home figure
Case example of the non-invasive and invasive assessment using the anatomical SYNTAX score and SYNTAX Score II. A 74-year-old man with a creatinine clearance 38 mL/min and left ventricular ejection fraction of 50% without history of chronic obstructive pulmonary disease or peripheral vascular disease. At the top, coronary computed tomography angiography shows three-vessel disease with a coronary narrowings located at the ostium and in the proximal segment of the right coronary artery; two narrowings located in the mid segment of the left anterior descending artery; and one additional narrowing in the proximal segment of the left circumflex artery involving the bifurcation with the first obtuse marginal coronary artery. Conventional angiography revealed also a three-vessel disease with one narrowing located at the proximal segment of the right coronary artery, one narrowing at the mid segment of the left anterior descending artery, and a bifurcation lesion involving the proximal segment of the left circumflex artery and the first obtuse marginal coronary artery. Each coronary narrowing was scored according to the anatomical SYNTAX score and the final anatomical SYNTAX score derived from each modality is shown. With both imaging modalities, the SYNTAX score II recommended either coronary artery bypass graft surgery or percutaneous coronary intervention based on a comparable predicted 4-year mortality. At the bottom, the non-invasive fractional flow reserve derived from coronary computed tomography angiography (FFRCT) is presented. The FFRCT showed that the lesions in the right coronary artery are not haemodynamically relevant, whereas the left anterior descending artery and left circumflex artery have haemodynamically relevant lesions. The treatment recommendation based on coronary computed tomography angiography with FFRCT remained equipoise between coronary artery bypass graft surgery and percutaneous coronary intervention but the treatment planning changed based on the negative FFRCT results in the right coronary artery. CABG, coronary artery bypass graft surgery; LAD, left anterior descending artery; LCX, left circumflex artery; PCI, percutaneous coronary intervention; RCA, right coronary artery.
Figure 2
Figure 2
Correlation and agreement on the anatomical SYNTAX score (A) and SYNTAX score II (B) between coronary computed tomography angiography and conventional angiography.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6241466/bin/ehy581f3.jpg

References

    1. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R.. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563–570.
    1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A.. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541–2619.
    1. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK.. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2014;130:1749–1767.
    1. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JA.. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 2008;359:2324–2336.
    1. Voros S, Rinehart S, Qian Z, Joshi P, Vazquez G, Fischer C, Belur P, Hulten E, Villines TC.. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 2011;4:537–548.
    1. Norgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Botker HE, Achenbach S; Group NXTTS. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol 2014;63:1145–1155.
    1. Papadopoulou SL, Girasis C, Dharampal A, Farooq V, Onuma Y, Rossi A, Morel MA, Krestin GP, Serruys PW, de Feyter PJ, Garcia Garcia HM.. CT-SYNTAX score: a feasibility and reproducibility study. JACC Cardiovasc Imaging 2013;6:413–415.
    1. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Stahle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW.. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639–650.
    1. Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Collet C, Albuquerque FN, Onuma Y, Park SJ, Serruys PW.. Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease. J Am Coll Cardiol 2016;68:999–1009.
    1. Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyasaki Y, Abdelghani M, Morel MA, Serruys PW.. Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial. EuroIntervention 2017;12:2001–2008.
    1. Sotomi Y, Collet C, Cavalcante R, Morel MA, Suwannasom P, Farooq V, van Gameren M, Onuma Y, Serruys PW.. Tools and techniques—clinical: SYNTAX score II calculator. EuroIntervention 2016;12:120–123.
    1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW.. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961–972.
    1. Andreini D, Pontone G, Mushtaq S, Mancini ME, Conte E, Guglielmo M, Volpato V, Annoni A, Baggiano A, Formenti A, Ditali V, Perchinunno M, Fiorentini C, Bartorelli AL, Pepi M.. Image quality and radiation dose of coronary CT angiography performed with whole-heart coverage CT scanner with intra-cycle motion correction algorithm in patients with atrial fibrillation. Eur Radiol 2018;28:1383–1392.
    1. Khan MF, Herzog C, Landenberger K, Maataoui A, Martens S, Ackermann H, Moritz A, Vogl TJ.. Visualisation of non-invasive coronary bypass imaging: 4-row vs. 16-row multidetector computed tomography. Eur Radiol 2005;15:118–126.
    1. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M.. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285–299.
    1. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW.. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009;5:50–56.
    1. Collet C, Miyazaki Y, Ryan N, Asano T, Tenekecioglu E, Sonck J, Andreini D, Sabate M, Brugaletta S, Stables RH, Bartorelli A, de Winter RJ, Katagiri Y, Chichareon P, De Maria GL, Suwannasom P, Cavalcante R, Jonker H, Morel MA, Cosyns B, Kappetein AP, Taggart DT, Farooq V, Escaned J, Banning A, Onuma Y, Serruys PW.. Fractional flow reserve derived from computed tomographic angiography in patients with multivessel CAD. J Am Coll Cardiol 2018;71:2756–2769.
    1. Mushtaq S, De Araujo Goncalves P, Garcia-Garcia HM, Pontone G, Bartorelli AL, Bertella E, Campos CM, Pepi M, Serruys PW, Andreini D.. Long-term prognostic effect of coronary atherosclerotic burden: validation of the computed tomography-Leaman score. Circ Cardiovasc Imaging 2015;8:e002332..
    1. Sim J, Wright CC.. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005;85:257–268.
    1. Bland JM, Altman DG.. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085–1087.
    1. Bablok W, Passing H, Bender R, Schneider B.. A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 1988;26:783–790.
    1. Vavere AL, Arbab-Zadeh A, Rochitte CE, Dewey M, Niinuma H, Gottlieb I, Clouse ME, Bush DE, Hoe JW, de Roos A, Cox C, Lima JA, Miller JM.. Coronary artery stenoses: accuracy of 64-detector row CT angiography in segments with mild, moderate, or severe calcification–a subanalysis of the CORE-64 trial. Radiology 2011;261:100–108.
    1. De Bruyne B, Pijls NHJ, Kalesan B, Barbato E, Tonino PAL, Piroth Z, Jagic N, Möbius-Winkler S, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF.. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991–1001.
    1. Escaned J, Collet C, Ryan N, Luigi De Maria G, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Ej West N, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es GA, Morel MA, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP.. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J 2017;38:3124–3134.

Source: PubMed

3
Tilaa